In C57Bl/6N mice fed a high-fat diet for 6 weeks, aerobic exercise training (AET) alone reduced adipocyte size, attenuated adipose tissue inflammation, and boosted skeletal muscle mitochondrial respiratory capacity. Adding dietary nitrate plus resveratrol (NR) produced no additional benefit in muscle or adipose tissue, but did selectively enhance liver outcomes: greater mitochondrial respiratory capacity, reduced reactive lipid accumulation, a distinct proteomic signature linked to altered amino acid metabolism, and meaningfully lower systemic fasting blood glucose beyond what AET achieved alone.
The liver-specificity of the NR effect is the most compelling detail here. Hepatic fat accumulation and mitochondrial dysfunction sit at the nexus of metabolic syndrome progression, and most exercise studies focus on muscle adaptations while the liver lags behind in recovery. That NR supplementation carved out a hepatic niche — without displacing exercise benefits elsewhere — suggests these interventions activate partially non-overlapping pathways despite sharing mitochondrial biogenesis machinery like SIRT1/PGC-1α signaling. The proteomic shift toward altered amino acid metabolism hints at deeper rewiring of hepatic substrate handling worth pursuing mechanistically.
Critical caveats apply: this is a male-only mouse model, and rodent hepatic lipid metabolism differs meaningfully from humans. Six weeks of intervention limits conclusions about long-term durability. Effect sizes are described as 'modest.' Nonetheless, for practitioners advising patients with early metabolic dysfunction who already exercise, this represents incremental but directionally interesting evidence that hepatic-targeted supplementation may fill a genuine gap exercise cannot fully close.
